K180344 is an FDA 510(k) clearance for the TheraCal DC. Classified as Liner, Cavity, Calcium Hydroxide (product code EJK), Class II - Special Controls.
Submitted by Bisco, Inc. (Schaumburg, US). The FDA issued a Cleared decision on April 5, 2018 after a review of 56 days - a notably fast clearance cycle.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3250 - the FDA dental device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.